These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 203619)

  • 1. Myocardial infarct imaging agents. III. Synthesis and evaluation of [203Hg] hydroxymercuriphthaleins.
    Hanson RN; Davis MA; Holman BL
    J Nucl Med; 1977 Dec; 18(12):1211-4. PubMed ID: 203619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiopharmaceuticals for acutely damaged myocardium. II: Synthesis and evaluation of [203Hg] hydroxymercurifluoresceins.
    Hanson RN; Davis MA; Holman BL
    J Nucl Med; 1977 Aug; 18(8):803-8. PubMed ID: 874169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of radiopharmaceuticals sequestered by acutely damaged myocardium.
    Davis MA; Holman BL; Carmel AN
    J Nucl Med; 1976 Oct; 17(10):911-7. PubMed ID: 184259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarct imaging with technetium-labeled complexes.
    Holman BL; Davis MA; Hanson RN
    Semin Nucl Med; 1977 Jan; 7(1):29-35. PubMed ID: 189440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial scintigraphy by infarct-avid radiotracers.
    Wynne J; Holman BL; Lesch M
    Prog Cardiovasc Dis; 1978; 20(4):243-66. PubMed ID: 202994
    [No Abstract]   [Full Text] [Related]  

  • 6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of phosphate radionuclide accumulation in a myocardial infarct focus].
    Shepeleva II; Rossel's AN
    Med Radiol (Mosk); 1979 Jan; 24(1):66-9. PubMed ID: 215866
    [No Abstract]   [Full Text] [Related]  

  • 8. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infarct avid (hot spot) myocardial scintigraphy.
    Holman BL; Wynne J
    Radiol Clin North Am; 1980 Dec; 18(3):487-99. PubMed ID: 6256808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m pyrophosphate myocardial imaging in perimyocarditis.
    Ahmad M; Dubiel JP
    J Nucl Med; 1981 May; 22(5):452-4. PubMed ID: 6260911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication.
    Wakat MA; Chilton HM; Hackshaw BT; Cowan RJ; Ball JD; Watson NE
    J Nucl Med; 1980 Mar; 21(3):203-6. PubMed ID: 6245193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specificity of pyrophosphate myocardial scintigrams in patients with prior myocardial infarction: concise communication.
    Botvinick EH; Shames DM; Sharpe DN; Klausner SC; Werner JA; Chatterjee K; Parmley WW
    J Nucl Med; 1978 Oct; 19(10):1121-5. PubMed ID: 214527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrophosphate imaging for infarct sizing.
    Bianco JA
    N Engl J Med; 1982 Jan; 306(2):110. PubMed ID: 6273727
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
    Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
    J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attempt at scintigraphic quantification of experimental myocardial infarct using pyrophosphate-labeled Tc 99m].
    Duska F; Vizda J; Kubícek J; Kafka P; Hájková B; Bastecký J; Morávek F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1977; 20(2-3):187-93. PubMed ID: 204988
    [No Abstract]   [Full Text] [Related]  

  • 16. Distributions of several agents useful in imaging myocardial infarcts.
    Bonte FJ; Parkey RW; Graham KD; Moore JG
    J Nucl Med; 1975 Feb; 16(2):132-5. PubMed ID: 162951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The scintigraphic demonstration of acute myocardial infarcts.
    Holman BL; Lesch M
    Compr Ther; 1976 Dec; 2(12):45-9. PubMed ID: 187370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of nuclear medicine to the diagnosis of myocardial infarct].
    Ando J; Yasuda H; Miyamoto A; Kobayashi T
    Nihon Rinsho; 1980 Oct; 38(10):4023-32. PubMed ID: 6265661
    [No Abstract]   [Full Text] [Related]  

  • 19. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
    J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scintigraphic demonstration of acute myocardial infarct with Tc-99m-pyrophosphate].
    Klein B; Falstie-Jensen N; Hansen TT
    Ugeskr Laeger; 1978 Mar; 140(10):533-6. PubMed ID: 204090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.